Cited by

• Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.

  Kostopoulos I, Karavasilis V, Karina M, Bobos M, Xiros N, Pentheroudakis G, Kafiri G, Papakostas P, Vrettou E, Fountzilas G. Kostopoulos I, et al. BMC Cancer. 2009 Sep 24;9:339. doi: 10.1186/1471-2407-9-339. BMC Cancer. 2009. PMID: 19775480 Free PMC article.
• Anastomotic leakage contributes to the risk for systemic recurrence in stage II colorectal cancer.

  Katoh H, Yamashita K, Wang G, Sato T, Nakamura T, Watanabe M. Katoh H, et al. J Gastrointest Surg. 2011 Jan;15(1):120-9. doi: 10.1007/s11605-010-1379-4. Epub 2010 Nov 18. J Gastrointest Surg. 2011. PMID: 21086058
• Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers.

  Ishida K, Nishizuka SS, Chiba T, Ikeda M, Kume K, Endo F, Katagiri H, Matsuo T, Noda H, Iwaya T, Yamada N, Fujiwara H, Takahashi M, Itabashi T, Uesugi N, Maesawa C, Tamura G, Sugai T, Otsuka K, Koeda K, Wakabayashi G. Ishida K, et al. PLoS One. 2012;7(8):e43236. doi: 10.1371/journal.pone.0043236. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22905237 Free PMC article.
• Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging?

  Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L. Mainenti PP, et al. World J Gastroenterol. 2011 Mar 21;17(11):1427-33. doi: 10.3748/wjg.v17.i11.1427. World J Gastroenterol. 2011. PMID: 21472100 Free PMC article.